Sutima Luangdilok

As seen in: MDPI

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sutima

Contact Sutima, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Vaccines | Free Full-Text | Safety following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac

Feb 03, 2023 |

By Panot Sainamthip, Passakorn Wanchaijiraboon, Nattaya Teeyapun, Sutima Luangdilok

| MDPI

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Sutima

Contact Sutima, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Sutima Luangdilok

Get in touch with Sutima

Actions

Is this you?

Articles

Vaccines | Free Full-Text | Safety following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac

Actions

Is this you?

Get in touch with Sutima